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Background: The scientific process around cancer research begins with scientific discovery, followed by
development of interventions, and finally delivery of needed interventions to people with cancer. Numerous studies
have identified substantial gaps between discovery and delivery in health research. Team science has been
identified as a possible solution for closing the discovery to delivery gap; however, little is known about effective
ways of collaborating within teams and across organizations. The purpose of this study was to determine benefits
and drawbacks associated with organizational collaboration across the discovery-development-delivery research
continuum.
Methods: Representatives of organizations working on cancer research across a state answered a survey about
how they collaborated with other cancer research organizations in the state and what benefits and drawbacks they
experienced while collaborating. We used exponential random graph modeling to determine the association
between these benefits and drawbacks and the presence of a collaboration tie between any two network
members.
Results: Different drawbacks and benefits were associated with discovery, development, and delivery collaborations.
The only consistent association across all three was with the drawback of difficulty due to geographic differences,
which was negatively associated with collaboration, indicating that those organizations that had collaborated were
less likely to perceive a barrier related to geography. The benefit, enhanced access to other knowledge, was positive
and significant in the development and delivery networks, indicating that collaborating organizations viewed
improved knowledge exchange as a benefit of collaboration. ‘Acquisition of additional funding or other resources’
and ‘development of new tools and methods’ were negatively significantly related to collaboration in these
networks. So, although improved knowledge access was an outcome of collaboration, more tangible outcomes were
not being realized. In the development network, those who collaborated were less likely to see ‘enhanced influence
on treatment and policy’ and ‘greater quality or frequency of publications’ as benefits of collaboration.
Conclusion: With the exception of the positive association between knowledge transfer and collaboration and the
negative association between geography and collaboration, the significant relationships identified in this study all
reflected challenges associated with inter-organizational collaboration. Understanding network structures and the
perceived drawbacks and benefits associated with collaboration will allow researchers to build and funders to
support successful collaborative teams and perhaps aid in closing the discovery to delivery gap.
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The National Cancer Institute describes the scientific
process around cancer research as a continuum begin-
ning with scientific discovery, followed by development
of interventions, and finally delivery of needed interven-
tions to people with cancer. This discovery-development-
delivery continuum conceptualization has been broadly
adopted across healthcare and public health. In recent
years, research identifying a major gap between discovery
and delivery has accumulated [1-6]. One commonly cited
study on the translation of medical discoveries into use
in clinical settings found that the process of discovery to
delivery takes an average of 17 years in the medical field
[7]. In 2007, Chambers and Kerner [8] described the
gap as follows: ‘Tested interventions are underutilized.
Used interventions are under-tested.’ There has been
some focus recently on scientific collaboration, or team
science, as an important part of translational research
that can help close the discovery to delivery gap [9-11].
Examples of this focus can be found in the text of
recent funding announcements for delivery or imple-
mentation science projects at the National Institutes of
Health (e.g., http://grants.nih.gov/grants/guide/pa-files/
PAR-07-086.html).
Scientific collaboration, or team science, can involve
researchers representing one or many fields from one or
many organizations [12]. At its best, collaborative sci-
ence incorporates diverse perspectives and stimulates
new insights into complex problems and solutions. At
its worst, conflicts based on longstanding scholarly dis-
agreements hinder or halt progress [12]. Scientific col-
laboration relies on relationships, making social network
analysis a uniquely useful tool in better understanding
collaborative efforts [13,14].
While there has been a great deal of research over the
past 20 years utilizing social network analysis [15], the
few studies that have examined scientific collaboration
using this perspective have focused on individual scien-
tists. Examining connections among individuals is highly
appropriate for trying to understand how ideas devel-
oped by one scientist or research team flow to another,
enhancing the process of discovery and/or the process of
moving ideas across the discovery-development-delivery
continuum. However, this individual approach does not
address how knowledge flows among organizations. This
flow is important because organizations, such as re-
search institutes or hospitals, often focus primarily on
one stage in the discovery-development-delivery process,
and may therefore represent narrow silos of knowledge.
This is likely a major reason why the gap between dis-
covery and delivery exists.
While networks of collaborative relationships that bring
together diverse organizations across the discovery-
development-delivery continuum would seem desirable,developing and maintaining such networks is fraught with
challenges [16,17]. Essentially, participating organizations
and those who work in them must recognize the advan-
tages of collaborating with other organizations, whether
within or across the discovery-development-delivery con-
tinuum, and must believe that the drawbacks to doing so
are minimal. Building on previous research that described
and compared the positions of individual organizations in
the discovery, development, and delivery networks [18], in
this study we focus on the relationships between organiza-
tions and examine the benefits and drawbacks associated
with collaboration within each type of network. Specific-
ally, we offer an explanation of the perceived benefits and
drawbacks associated with collaborative relationships be-
tween organizations and how these benefits and draw-
backs to collaboration might vary depending on the type
(discovery, development, delivery) of cancer research
being conducted. In doing so, we contribute to existing
knowledge and approaches for understanding and evaluat-
ing collaborative science in two primary ways: we identify
benefits and drawbacks associated with collaboration
across the discovery-development-delivery continuum that
will aid funders and researchers in strategically developing
and managing research teams; and we demonstrate the
use of exponential random graph modeling, which is a
uniquely useful and accessible, yet underutilized, tool for
understanding collaboration.
Methods
Representatives of organizations involved in cancer re-
search across Arizona that were represented on the re-
search committee for the Arizona Cancer Control
Program were invited to participate by completing a sur-
vey [18]. The Program is comprised of academic institu-
tions, hospitals, the state health department, research
institutes, and non-profit organizations involved in can-
cer research. The Program was formed by the Arizona
Department of Health Services as part of a grant from
the Centers for Disease Control and Prevention in 2003
to establish a comprehensive cancer control program.
To identify members of the Program actively involved in
cancer research, a working group comprised of Program
research committee members reviewed research com-
mittee membership and identified 34 organizations. All
34 organizations were contacted; nine organizations
indicated they were not involved in cancer research and
several hospitals were found to be part of multi-hospital
systems for which a single participant would be appro-
priate. After addressing these issues, the network con-
sisted of 21 members. Most participating organizations
named an administrative or medical director of cancer
services or a director of research activities as the survey
participant. Surveys were administered in 2007 with
some follow-up to gather missing information in 2008.
Table 1 Percentage of organizations identifying each of
15 benefits and drawbacks of collaboration among
organizations working on cancer research across Arizona
Benefits % (n)
Acquisition of additional funding or other resources 88.9 (16)
Enhanced access to other knowledge 88.9 (16)
Enhanced reputation of my organization 83.3 (15)
Enhanced impact on other researchers 77.8 (14)
Enhanced influence on treatment and policy 72.2 (13)
Greater quality or frequency of publications 72.2 (13)
Improved access to study subjects or data 72.2 (13)
Development of new tools and methods 72.2 (13)
Drawbacks
Frustration or aggravation in dealing with partners 72.2 (13)
Diversion of time and resources from other activities 61.1 (11)
Insufficient resources to support effective collaboration 61.1 (11)
Insufficient credit given to what my organization does 55.6 (10)
Difficulty due to geographical distances 50.0 (9)
Strained relations within my own organization 33.3 (6)
Loss of control/autonomy over decisions 27.8 (5)
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versity of Arizona Institutional Review Board approved
the study.
Measures
In the survey, a list was provided of each of the organi-
zations and the participant from each organization was
asked to ‘please go through the list below and indicate
with which organizations your organization/unit has
been involved in its cancer control research for each
type of research – discovery, development, and delivery.’
Operational examples of discovery, development, and
delivery were provided along with examples of collabora-
tive involvement:
1. Discovery: tissue sharing, basic scientific research,
etc.
2. Development: synthesis of new knowledge,
developing new treatments and drugs, developing
new community programs, etc.
3. Delivery: research on delivery of treatment to
patients, prevention and early detection, etc.
4. Collaborative involvement: shared personnel, shared
information, joint programs, joint funding, shared
facilities and equipment, support, advice, etc.
In addition, participants were asked to estimate the
percent of time their organization’s cancer resources
were spent on each of discovery, development, and de-
livery by responding to the following: Please estimate the
percent of your organization’s/unit’s total cancer re-
search resources that are spent on the following activ-
ities (note that the total should equal 100%): discovery
(tissue sharing, basic research, etc.) ________%; develop-
ment (synthesis of new knowledge, developing new
treatment or drugs, etc.): _______ %; delivery (research
on delivery of treatment to patients, research on preven-
tion and detection, etc.): ______ %.
Finally, organizational representatives were asked to
identify the benefits and drawbacks their organization
had experienced during collaborations with other cancer
research organizations. The list of benefits and draw-
backs was developed based on earlier work by Provan
et al. [19] combined with discussions with Program re-
search committee members. For each drawback or bene-
fit, respondents were asked to indicate whether the
particular benefit and drawback ‘did not occur,’ ‘may
have occurred,’ or ‘definitely occurred’ (Table 1).
Data management
Three non-responders were dropped from analyses. Eighty
to ninety percent of the pairs of network members, or
dyads, in each of the three networks (discovery collabor-
ation network, development collaboration network, anddelivery collaboration network) agreed either that there
was no collaboration (0) or there was collaboration (1) be-
tween them. However, a minority of dyads in each net-
work consisted of members who disagreed (one member
of the dyad indicated no collaboration while the other
indicated collaboration). With 18 network members in an
undirected network, there are 153 unique dyads (dyads =
n*(n-1)/2). In the discovery network, 16 of the 153 dyads
included a disagreement between the two network mem-
bers in the dyad. In the development network, 30 of 153
dyads disagreed. In the delivery network, 27 of 153 dyads
disagreed. Collaboration is inherently bi-directional (if I
collaborate with you, you collaborate with me) so it was
necessary to decide whether the dyads with disagreement
would be coded as no collaboration or collaboration.
In previous work using these data, Provan et al. used
confirmed ties only (i.e., dyads where both members
agreed there was a tie) [18]. Because the focus of that
study was on explaining overall network structure, full
agreement about the presence of every tie was an appro-
priate conservative approach for indicating who was
connected to whom. For the analyses reported here, we
decided to represent disagreements as collaborations.
Methodologically, there are no specific coding rules for
statistical analysis of networks regarding using con-
firmed ties or all ties [20], so the selection of a data
management strategy is based on what is most appropri-
ate for the study at hand. In this case, the recognition of
a collaborative research tie between any two organiza-
tions might depend on whether the respondent him/
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of, the collaboration. In addition, this study’s focus is on
the relationship between dyadic ties and attitudes
(regarding benefits and drawbacks) and not, as the previ-
ous study was, on whole network structure per se, sug-
gesting the value of retaining all ties.
In addition to symmetrizing the network, we dichoto-
mized the answers to the drawback and benefit ques-
tions. Participants selected from 0 (did not occur), 1
(may have occurred), and 2 (definitely occurred). Given
the limited range of values and the large number of
drawbacks/benefits, we dichotomized each to drawback
or benefit to 0 (did not occur) and 1 (may have or defin-
itely occurred). Phi correlations among the dichotomized
benefits and drawbacks were examined to ensure that
variables were capturing unique information. The bene-
fits of publication and reputation were correlated at
ϕ= 0.72 and the benefits of reputation and knowledge
were correlated at ϕ= 0.79. The reputation benefit was
therefore removed from analyses.
Finally, to examine whether there were important differ-
ences resulting from using all ties rather than confirmed
ties, we conducted a sensitivity analysis comparing the
patterns of benefits and drawbacks in networks with all
ties and with confirmed ties only. This analysis revealed
similar patterns across the networks resulting from these
two data management strategies. The similarity was espe-
cially apparent for the discovery and delivery networks,
which were the networks with fewer disagreements about
ties in dyads.
Analysis
We conducted descriptive, visual, and statistical analyses
to examine the discovery, development, and delivery net-
works. Descriptive measures included network density,
distribution of links per network member (degree distri-
bution), and number of triangles in each network.
In addition to general network measures, we used an
ERG-p* modeling (ERGM) strategy to develop statistical
models predicting the likelihood of a tie between two
network members based on characteristics of the net-
work members, characteristics of their relationships, and
general structural features of the network. In this type of
modeling, the outcome is similar to logistic regression,
but at the level of the dyad instead of the individual.
That is, the model estimates the probability of a tie be-
tween any two network members; the sample size of
interest, therefore, is the total number of dyads or pos-
sible ties in the network (n = 153). In the discovery net-
work, a tie would indicate collaboration between two
organizations on discovery research; in the development
network, a tie indicated collaboration on development;
and in the delivery network, a tie indicated collaboration
on delivery of cancer research.ERGMs were developed to examine the relationship
between the drawbacks and benefits perceived by the
organizations and the discovery, development, and deliv-
ery collaborations among these organizations. That is,
we sought to determine which drawbacks and benefits
were associated with increased or decreased likelihood
of collaboration among cancer research organizations
across the discovery-development-delivery continuum.
Following Goodreau [21], ERGMs were developed in
steps, starting with a null model, adding organizational
characteristics, and, finally, adding terms designed to ac-
count for underlying global network structures.
The two global structures that are often found in
observed networks, but are not well captured by statis-
tical network models, are a non-uniform degree distribu-
tion and excess transitivity. A non-uniform degree
distribution is the result of some network members hav-
ing few connections, while other network members have
many connections. The non-uniform degree distribution
is often decreasing at a geometric rate in observed net-
works, with a large proportion of nodes being isolated or
having very few connections and only a few nodes hav-
ing many connections. This property of the degree dis-
tribution is captured by the geometrically weighted
degree (GWD) term in statistical models of networks.
Transitivity is the relational quality that is expressed
by the adage ‘the-friend-of-my-friend-is-my-friend’ and
manifests in networks as triangle structures, where there
is a link between A and B, a link between B and C, and
a link between A and C, forming a triangle. Two terms
account for transitivity in a network: the geometrically
weighted edgewise shared partners (GWESP) accounts
for partners shared by two connected nodes (a con-
nected triangle), and the geometrically weighted dyad-
wise shared partners (GWDSP) accounts for partners
shared by two nodes regardless of whether they are
linked (a triangle with or without a base).
When models with all three geometric terms did not
converge, we followed a strategy demonstrated by
Hunter et al. using bivariate analyses to determine which
of the geometric terms may be helpful in explaining
existing global network structures [22,23]. The full
model was then re-estimated retaining only those global
terms that demonstrated a significant relationship with
the outcome in this bivariate testing.
Model fit was examined at each step. Statistical mea-
sures of model fit, such as the Akaike Information Cri-
terion (AIC) and Bayesian Information Criterion (BIC),
may not be suitable for assessing statistical network
models because network data do not meet necessary
assumptions [22]. Therefore, graphic measures of fit
based on examining a set of simulated networks were
the primary tools used to select the final models. Specif-
ically, the number of triangles in simulated networks
Table 2 The proportion of time spent by each
organization on discovery, development, delivery
research activities
ID % Discovery % Development % Delivery
1 25 50 25
2 15 35 50
3 0 38 63
4 12 28 60
5 83 17 0
6 40 10 50
7 5 0 95
8 0 0 100
9 30 25 45
10 50 0 50
11 5 5 90
12 0 0 100
13 40 40 20
14 60 0 40
15 75 15 10
16 0 0 0
17 75 10 15
18 10 20 70
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triangles in each model; similarly, we compared the
observed degree distribution with the degree distribution
for networks simulated based on the model. The
models that produced simulated networks most closelyFigure 1 Discovery, development, and delivery networks with nodes
organization spends the most time on related to cancer research.approximating the observed network were selected as
final models. Statistical network modeling was con-
ducted using R-statnet.
Results
The average number of benefits and drawbacks identi-
fied by each of the organizations was 9.06 (sd = 3.37),
with a greater number of benefits (m= 5.44; sd = 2.01)
than drawbacks (m= 3.61; sd = 1.91) to collaborating
identified. The fewest organizations (n = 5) selected ‘loss
of control/autonomy over decisions,’ while the most
organizations (n = 16) identified ‘acquisition of additional
funding or other resources’ and ‘enhanced access to
other knowledge’ as characteristics of their collabora-
tions. The proportion of organizations that selected each
benefit and drawback is shown in Table 1.
Organizations spent an average of 29.17% (sd = 28.87)
of their cancer research resources on discovery research;
16.28% (sd = 16.36) on development; and 49.06% (sd =
33.21) on delivery. Table 2 shows the proportion of time
on each activity for each of the 18 organizations. Four
organizations reported no discovery research, six
reported no development, and two reported no delivery.
Two organizations reported spending 100% of their can-
cer research time on delivery research; all other organi-
zations reported dividing their time between two or
three of the discovery-development-delivery activities.
Only one organization reported more resources going to
development than to other activities. Figure 1 shows the
three networks with organizations colored by the area
where they spent the most cancer resources.sized by degree centrality and colored by the area the
Table 3 Descriptive network statistics for the discovery,
development, and delivery collaboration networks
Discovery Development Delivery Average (sd)
Density 0.29 0.26 0.30 0.28 (.02)
Degree (mean, sd) 9.78 (7.79) 8.89 (7.04) 10.22 (7.94) 9.63 (7.59)
Number of triangles 43 30 48 40.3
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ity; those with high degree centrality are well connected
within the network. The one organization focused on de-
velopment was most central in the development and deliv-
ery networks. In the delivery network, three of the four
organizations focused on discovery were connected to the
rest of the network only through their collaboration with
the development-focused organization (Figure 1). In
addition to being the most centralized, the delivery network
was the densest network of the three indicating that more
collaboration occurs around delivery than around discovery
or development in this group of organizations. Table 3
shows average degree and other basic characteristics.Figure 2 Comparison of degree distribution and transitivity in simula
(right). Gray arrows (top) and thick black lines (bottom) represent the obse
the simulated networks based on each model.Discovery model
The full model including the three geometrically weighted
terms did not converge. GWD and GWDSP were non-
significant in bivariate analyses. These were removed and
the full model was re-estimated. Goodness-of-fit plots (Fig-
ure 2) indicated that the characteristics-only model (Model
2) fit the data better than the full model (Model 3). Model
2 was selected as the final model for discovery (Table 4).
In the final discovery model, only the drawback of geo-
graphical distance was significantly associated with dis-
covery collaboration. The negative association between
collaboration and distance indicates that organizations
collaborating in this network were less likely to see geo-
graphical distances as a barrier. Table 3 shows the mod-
els for discovery, development, and delivery, with each
final model indicated by the black box around it.Development model
Like the discovery model, the full model for the develop-
ment network did not converge with all three global
terms. After testing, GWDSP and GWESP remained in
the model. Goodness-of-fit plots were notably better fortions based on discovery model 2 (left) and discovery model 3
rved network, while the histogram (top) and boxplots (bottom) show
Table 4 Statistical network models of drawbacks and benefits associated with collaboration across the discovery-development-delivery continuum in a
network of organizations working on cancer



















Edges -.90 (.18)* −5.71 (2.24)* −8.44 (1.52)* −1.04 (.18)* −3.83 (1.79)* −5.69 (1.41)* -.84 (.18) −3.84 (1.75)* −2.57 (3.80)
Organizational characteristics (node attributes)
% time discovery 0.06 (0.05) .08 (.02)* na na na na
% time development na na 0.08 (0.03)* .02 (.04) na na
% time delivery na na na na −0.05 (0.03) .51 (.06)*
Benefits
Enhanced influence on treatment and policy −3.03 (3.86) −2.36 (.77)* −5.11 (1.55)* -.52 (.85) −4.2 (2.21) 21.06 (8.85)*
Enhanced impact on other researchers 3.63 (2.07) 2.74 (.06)* 1.87 (1.45) 6.86 (.08)* 1.58 (1.68) 39.22 (.15)
Greater quality or frequency of publications −1.95 (2.04) −1.39 (.06)* −1.69 (0.64)* −1.61 (.08)* −0.15 (1.23) −22.56 (.17)*
Acquisition of additional funding or other resources −5.07 (2.90) −5.55 (.06)* −5.63 (1.92)* −3.21 (.10)* −12.14 (3.45)* 24.88 (1.27)*
Improved access to study subjects or data 1.33 (1.37) 2.06 (.07)* −1.15 (1.18) .86 (.08)* −1.31 (1.14) 20.43 (.14)*
Enhanced access to other knowledge 7.55 (6.09) 6.78 (.06)* 12.72 (4.03)* −2.23 (.09)* 25.43 (7.5)* −138.47 (.15)
Development of new tools and methods −2.5 (1.64) −2.44 (.07)* −2.29 (1.14)* .33 (.09)* −4.61 (1.56)* 17.19 (.16)*
Drawbacks
Diversion of time and resources from other activities −1.1 (1.41) −1.52 (.57)* 1.1 (0.69) -.04 (.93) −2.87 (0.81)* .04 (2.71)
Insufficient resources to support effective collaboration 2.48 (1.73) 2.41 (.08)* 2.1 (1.11) -.13 (.09) 4.78 (1.55)* −8.30 (2.20)*
Loss of control/autonomy over decisions 3.15 (1.92) 2.82 (.49)* 2.76 (1.41) -3.30 (1.07)* 9.48 (2.98)* −58.55 (8.72)*
Strained relations within my own organization 0.74 (2.05) .93 (.14)* −1.43 (1.13) .13 (.66) −1.75 (1.35) -.35 (7.94)
Frustration or aggravation in dealing with partners 1.35 (1.57) 1.99 (.62)* −0.14 (1.14) -.78 (1.21) 5.19 (1.52)* −8.65 (8.19)
Insufficient credit given to what my organization does −2.02 (1.62) −2.18 (.71)* −1.38 (1.04) 1.57 (.70) −9.16 (2.31)* 31.84 (4.60)*
Difficulty due to geographical differences −4.63 (1.20)* −4.30 (.38)* −3.98 (1.04)* 1.30 (.80) −8.17 (2.28)* 44.04 (7.45)*
Geometric terms (Global structural terms)
Geometrically weighted degree (GWD) na na −17.54 (2.38)*
Geometrically weighted dyadwise shared partners (GWDSP) na 1.10 (.10)* 17.49 (.42)





















Figure 3 Comparison of degree distribution and transitivity in simulations based on development model 2 (left) and development
model 3 (right). Gray arrows (top) and thick black lines (bottom) represent the observed network, while the histogram (top) and boxplots
(bottom) show the simulated networks based on each model.
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the final development model.
Several benefits and one drawback (geography) were sig-
nificantly associated with collaboration around develop-
ment. Organizations collaborating on development were
less likely to perceive: ‘enhanced influence on treatment
and policy,’ ‘greater quality or frequency of publications,’
‘acquisition of additional funding or other resources,’ and
‘development of new tools and methods.’ However, collab-
orating organizations were more likely to report ‘enhanced
access to other knowledge.’ Consistent with the discovery
network, geography and collaboration were negatively
associated; that is, organizations collaborating on develop-
ment were less likely to find geographic distance as a
barrier.
Delivery model
The delivery full model converged with all three geomet-
ric terms. However, based on goodness-of-fit plots, the
full model was not a good fit and the characteristics only
model was adopted (Table 4; Figure 4). Three benefits
and six drawbacks were associated with delivery collab-
oration. Of the three benefits, only ‘enhanced access toother knowledge’ was positively related to a delivery col-
laboration. Significant drawbacks were equally divided
between positive and negative association with delivery
collaboration. Consistent with the other two networks,
organizations collaborating on delivery were also less
likely to identify geography as a barrier. The delivery
model was the only model of the three to have multiple
significant drawbacks associated with collaboration.
Discussion and conclusions
Drawing from a social network perspective, we used net-
workmeasures and statistical networkmodeling to examine
the drawbacks and benefits associated with collaboration
around discovery, development, and delivery in a network
of organizations conducting cancer research. Examination
of degree centrality in the networks demonstrated the im-
portant role of the one development-focused organization.
Given the central role of development as the translator
of research from discovery to delivery in the discovery-
development-delivery continuum, the central position of
the development-focused organization in the network
makes intuitive sense, especially given the lack of add-
itional organizations with a development focus. Public
Figure 4 Comparison of degree distribution and transitivity in simulations based on delivery model 2 (left) and delivery model 3
(right). Gray arrows (top) and thick black lines (bottom) represent the observed network, while the histogram (top) and boxplots (bottom) show
the simulated networks based on each model.
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ant role and work to identify or cultivate partners with a
focus on development or translational research.
The statistical network models identified a few similar-
ities across the networks; however, in general, we found
that different drawbacks and benefits were associated with
each of the three stages in the discovery-development-
delivery continuum. One consistent finding was that the
drawback, ‘difficulty due to geographical differences,’ was
negative and significant across all three networks indicat-
ing that collaborating organizations, regardless of the stage
of research, were less likely to perceive geography as a bar-
rier than organizations not collaborating. This finding is
inconsistent with past research and may demonstrate a
difference between perceptions and actual experience
when it comes to long-distance collaboration. Specifically,
a recent study on national tobacco control networks [24]
found that the further apart organizations were geograph-
ically, the less likely they were to collaborate. It seems
likely that these organizations perceived distance as a bar-
rier, and therefore, did not pursue collaboration. Other
studies have found that collaboration between multiple
sites across distance is complex [25], despite the availabil-
ity of numerous sophisticated communication technolo-
gies [26]. This complexity can lead to fewer project
activities being conducted and fewer outcomes achieved
[25]. In contrast, our findings indicate that onceorganizations are actually working together, geographical
distance is no longer seen as a barrier.
Identification of geography as a barrier more closely
related to perception than based on experience presents
a challenge for the Centers for Disease Control and Pre-
vention in their goal of developing Cancer Control coali-
tions in states. It may be necessary for additional effort
to be placed on identifying and implementing ways to
reduce the negative perception of geography as a barrier
in order to encourage organizations that are more dis-
tant to make the effort to collaborate. For example, add-
itional strategies such as the use of videoconferencing to
foster increased communication may aid in addressing
the problem. Such increased communication could also
ameliorate other barriers.
In the delivery network, organizations that were collab-
orating were more likely to perceive ‘insufficient resources
to support effective collaboration,’ ‘loss of control/auton-
omy over decisions,’ and ‘frustration or aggravation in deal-
ing with partners’ as barriers to collaboration. Past research
on team science in the delivery phase has stressed leader-
ship and minimizing barriers; while this study does not ad-
dress leadership, the existence of numerous barriers in the
delivery network confirm this prior finding [27]. The per-
ception of these barriers in the delivery network may sig-
nify the ‘growing pains’ that are likely to be encountered by
organizations engaged in this emerging area of research.
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may face challenges in bringing together stakeholders with
varied expectations, goals, and incentives for collaboration.
The positive association with insufficient resources, in par-
ticular, may be due to underestimating the resources
needed to support the collaborations once they were
initiated.
The National Cancer Institute (NCI) has identified,
or re-framed, delivery science as implementation science
(http://cancercontrol.cancer.gov/IS/definitions.html), which
is defined as, ‘. . .the scientific study of methods to
promote the integration of research findings and
evidence-based interventions into healthcare policy
and practice, and hence, to improve the quality and
effectiveness of health services and care’ [28]. One of
the goals of the NCI regarding implementation science
is to build partnerships for the development, dissem-
ination, and implementation of evidence-based mea-
sures, initiatives, and programs (http://cancercontrol.
cancer.gov/IS/about.html). However, because research
on collaborative science is also new and developing,
there is limited information about how to build these
partnerships in effective ways, building on benefits
and minimizing drawbacks. While new funding
mechanisms for implementation science are available
(http://cancercontrol.cancer.gov/IS/index.html) and en-
courage transdisciplinary teams to apply, there is
much that is not known about how the organizations
that employ scientists interact. The findings reported
here attempt to move this line of research forward. In
addition, statistical network approaches like ERGM
are becoming more accessible and widely used, pro-
viding a new way to examine how specific benefits
and drawbacks, along with other characteristics, are
associated with collaboration. As implementation sci-
ence continues to develop at both the team and
organizational levels, and as new tools and approaches
are developed, like ERGM, to evaluate collaborative
interactions, new information on how to structure
effective teams and partnerships will likely emerge.
Three benefits were consistent in direction and signifi-
cance across the development and delivery networks.
The benefit, ‘enhanced access to other knowledge,’ was
positive and significant in both networks indicating that
organizations that were collaborating view improved
knowledge exchange as a benefit of the collaboration.
However, ‘acquisition of additional funding or other
resources’ and ‘development of new tools and methods’
were both negative and significantly related to collabor-
ation. So, although improved knowledge access is a likely
outcome of collaboration, which is consistent with re-
search in other fields [29,30], tangible outcomes of these
collaborations including tools, methods, and funding are
not being realized. These benefits may be more difficultto attain than others and may require more intensive
collaboration over a longer period of time, possibly in-
cluding the utilization of new approaches to communi-
cation to overcome barriers discussed above.
Additional significant benefits were identified in the
Development network including negative associations
between collaboration and the benefits of ‘enhanced in-
fluence on treatment and policy’ and ‘quality or fre-
quency of publications.’ These may be serious challenges
to collaboration at this level because the primary motiv-
ation of many researchers is to improve treatment or
change policy. The rewards of developmental research
may be more distal, with change occurring at the deliv-
ery step. At research-focused institutions and among
junior faculty, the lack of direct influence on treatment
and policy and the perception of reduced quality and
frequency of publications is likely to dissuade collabor-
ation on development projects. A few of the benefits
were selected by nearly all of the participants, indicating
consistent positive experiences following collaboration
across the cancer research spectrum.
The findings of this study are limited in a few ways.
First, the cross-sectional design does not allow examin-
ation of collaborations over time, thus limiting any under-
standing of how benefits and drawbacks emerge and
change. Second, the limitation of examining a single coali-
tion of organizations precludes generalizing findings to a
larger population of cancer coalitions or other public
health networks. Third, some of the variation in the iden-
tification of barriers and drawbacks was lost when these
variables were dichotomized. Fourth, missing data
prompted dropping three of the organizations in the
study. We also recognize that other variables, such as
readiness for collaboration [31], availability of collabor-
ation technology [26], existence of collaborative leadership
[32], and having supportive administrative infrastructures
[31] might well provide additional understanding of when,
why, and how collaboration across organizations takes
place and whether it is successful or unsuccessful. Finally,
despite the fact that use of a single key informant is com-
mon in studies of organizational networks, we recognize
the shortcomings of this approach, especially for assessing
benefits and drawbacks, which could reflect personal ra-
ther than organizational views. Despite these limitations,
our study is the first we are aware of to examine the bene-
fits and drawbacks associated with research collaboration
along the discovery-development-delivery continuum.
Thus, our work contributes to a deeper understanding of
implementation science, especially as it occurs across
organizations.
Given the importance of understanding how research
moves along the discovery-development-delivery con-
tinuum, and the role of collaborative efforts in advancing
science, it will be important for future studies to
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ciated with collaboration at each phase of the research
continuum. It is of particular importance, also, to gain
understanding about how the benefits and drawbacks in-
fluence the flow of knowledge from discovery to deliv-
ery. For example, once a research team has made a
discovery, what are the specific benefits and drawbacks
to continuing to work as a team to translate the discov-
ery from the lab to the clinic, and to what extent do the
organizations that employ the scientists either facilitate
or hinder successful interactions? In addition, informa-
tion about how drawbacks might be mitigated or bene-
fits might be strengthened is needed. Further
investigation of these and related issues would be espe-
cially helpful to those who are involved in the research
process, and also to health policy officials and funders in
developing incentives for researchers in cancer and other
areas to collaborate across organizations and across the
research continuum.
For funders in particular, understanding what scientists
perceive as the benefits and challenges of collaborative
research is important for shaping research initiatives,
which not only encourage, but often require, collabor-
ation. Based on our findings, scientists recognized that
collaboration led to benefits like enhanced access to
knowledge and breaking down perceived barriers due to
geographical distance. However, we also found some
benefits, like ‘acquisition of additional funding or other
resources,’ were not perceived as likely outcomes of
collaboration, while others, such as ‘enhanced influence
on treatment and policy,’ were negatively related to
collaboration. Funding agencies may wish to evaluate
funded projects to identify strategies used by collabora-
tive research teams that were successful in acquiring add-
itional funding, improving treatment or policy, and other
areas. Funders could then provide guidance and specific
examples of the benefits of collaborative research in
order to help scientists recognize its potential. As
evidence about the benefits and drawbacks of collabora-
tive science accumulates, funders may wish to adapt
the collaboration requirements of research initiatives
accordingly.
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